Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosterone

Biochemical and Biophysical Research Communications

Volumn 318, Issue 1, 2004, Pages 281-288

  Rossol Haseroth, Karin ^a   Zhou, Qian ^a   Braun, Sabine ^a   Boldyreff, Brigitte ^a   Falkenstein, Elisabeth ^a   Wehling, Martin ^a   Lösel, Ralf M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Collecting duct; ERK; MAPkinase; Mineralocorticoid receptor antagonists; Nongenomic; Rapid responses; Spironolactone

Indexed keywords

ALDOSTERONE; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; HORMONAL REGULATION; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; BUTADIENES; CELL LINE; CYCLOHEXIMIDE; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HYDROCORTISONE; KIDNEY CORTEX; KIDNEY TUBULES, COLLECTING; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTORS, MINERALOCORTICOID;

EID: 1942521021     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.026     Document Type: Article

References (45)

1. Booth R.E., Johnson J.P., Stockand J.D. Aldosterone. Adv. Physiol. Educ. 26:2002;8-20.
2. Wehling M. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59:1997;365-393.
3. Haseroth K., Gerdes D., Berger S., Feuring M., Gunther A., Herbst C., Christ M., Wehling M. Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice. Biochem. Biophys. Res. Commun. 266:1999;257-261.
4. Falkenstein E., Tillmann H.C., Christ M., Feuring M., Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol. Rev. 52:2000;513-556.
5. Eisen C., Meyer C., Christ M., Theisen K., Wehling M. Novel membrane receptors for aldosterone in human lymphocytes: a 50. kDa protein on SDS-PAGE Cell. Mol. Biol. (Noisy-le-grand). 40:1994;351-358.
6. 2+ in M-1 cortical collecting duct cells. Kidney Int. 57:2000;1395-1403.
7. Manegold J.C., Falkenstein E., Wehling M., Christ M. Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cells. Cell. Mol. Biol. (Noisy-le-grand). 45:1999;805-813.
8. Christ M., Gunther A., Heck M., Schmidt B.M., Falkenstein E., Wehling M. Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells. Circulation. 99:1999;1485-1491.
9. Stoos B.A., Naray-Fejes-Toth A., Carretero O.A., Ito S., Fejes-Toth G. Characterization of a mouse cortical collecting duct cell line. Kidney Int. 39:1991;1168-1175.
10. Stockand J.D., Meszaros J.G. Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am. J. Physiol. Heart Circ. Physiol. 284:2003;H176-H184.
11. +-exchange in MDCK cells by aldosterone involves MAP-kinase ERK1/2. Pflügers Arch. 441:2001;781-786.
12. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E., Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1996;1292-1300.
13. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem. Biophys. Res. Commun. 241:1997;419-426.
14. Chen S.Y., Wang J., Liu W., Pearce D. Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor. Am. J. Physiol. 274:1998;C39-C46.
15. Alzamora R., Michea L., Marusic E.T. Role of 11b-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension. 35:2000;1099-1104.
16. Ahn N.G., Robbins D.J., Haycock J.W., Seger R., Cobb M.H., Krebs E.G. Identification of an activator of the microtubule-associated protein 2 kinases ERK1 and ERK2 in PC12 cells stimulated with nerve growth factor or bradykinin. J. Neurochem. 59:1992;147-156.
17. Payne E., Bowles M.R., Don A., Hancock J.F., McMillan N.A. Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation. J. Virol. 75:2001;4150-4157.
18. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 242:1988;583-585.
19. Muto S., Giebisch G., Sansom S. Effects of adrenalectomy on CCD: evidence for differential response of two cell types. Am. J. Physiol. 253:1987;F742-F752.
20. Krug A.W., Schuster C., Gassner B., Freudinger R., Mildenberger S., Troppmair J., Gekle M. Human epidermal growth factor receptor-1 expression renders chinese hamster ovary cells sensitive to alternative aldosterone signaling. J. Biol. Chem. 277:2002;45892-45897.
21. Gekle M., Freudinger R., Mildenberger S., Silbernagl S. Rapid actions of aldosterone on cells from renal epithelium: the possible role of EGF-receptor signaling. Steroids. 67:2002;499-504.
22. Gekle M., Freudinger R., Mildenberger S., Silbernagl S. Aldosterone interaction with epidermal growth factor receptor signaling in MDCK cells. Am. J. Physiol. Renal Physiol. 282:2002;F669-F679.
23. Hendron E., Stockand J.D. Activation of mitogen-activated protein kinase (mitogen-activated protein kinase/extracellular signal-regulated kinase) cascade by aldosterone. Mol. Biol. Cell. 13:2002;3042-3054.
24. Qiu J., Wang P., Jing Q., Zhang W., Li X., Zhong Y., Sun G., Pei G., Chen Y. Rapid activation of ERK1/2 mitogen-activated protein kinase by corticosterone in PC12 cells. Biochem. Biophys. Res. Commun. 287:2001;1017-1024.
25. Liu S.L., Schmuck S., Chorazcyzewski J.Z., Gros R., Feldman R.D. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation. 108:2003;2400-2406.
26. Sato A., Liu J.P., Funder J.W. Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro. Endocrinology. 138:1997;3410-3416.
27. Mihailidou A.S., Mardini M., Funder J.W. Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C. Endocrinology. 145:2004;773-780.
28. Funder J.W. Non-genomic actions of aldosterone: role in hypertension. Curr. Opin. Nephrol. Hypertens. 10:2001;227-230.
29. Naray-Fejes-Toth A., Fejes-Toth G. Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am. J. Physiol. 259:1990;F672-678.
30. Nakhoul N.L., Hering-Smith K.S., Gambala C.T., Hamm L.L. Regulation of sodium transport in M-1 cells. Am. J. Physiol. 275:1998;F998-F1007.
31. Christ M., Sippel K., Eisen C., Wehling M. Non-classical receptors for aldosterone in plasma membranes from pig kidneys. Mol. Cell. Endocrinol. 99:1994;R31-R34.
32. Pappas T.C., Gametchu B., Watson C.S. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 9:1995;404-410.
33. Shaul P.W. Rapid activation of endothelial nitric oxide synthase by estrogen. Steroids. 64:1999;28-34.
34. Lösel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C., Rossol-Haseroth K., Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83:2003;965-1016.
35. Winter D.C., Schneider M.F., O'Sullivan G.C., Harvey B.J., Geibel J.P. Rapid effects of aldosterone on sodium-hydrogen exchange in isolated colonic crypts. J. Membr. Biol. 170:1999;17-26.
36. 3 action in renal thick ascending limb via a nongenomic, ERK-dependent pathway. Am. J. Physiol. Cell Physiol. 285:2003;C1122-C1130.
37. Zhao J., Yuan X., Frodin M., Grummt I. ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Mol. Cell. 11:2003;405-413.
38. Chen D.B., Davis J.S. Epidermal growth factor induces c-fos and c-jun mRNA via Raf-1/MEK1/ERK-dependent and -independent pathways in bovine luteal cells. Mol. Cell. Endocrinol. 200:2003;141-154.
39. Chen S.L., Chang Y.J., Wu Y.H., Lin K.H. Mitogen-activated protein kinases potentiate thyroid hormone receptor transcriptional activity by stabilizing its protein. Endocrinology. 144:2003;1407-1419.
40. de Borst M.H., Navis G., de Boer R.A., Huitema S., Vis L.M., van Gilst W.H., van Goor H. Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats. Lab. Invest. 83:2003;1761-1770.
41. Wehling M., Spes C.H., Win N., Janson C.P., Schmidt B.M., Theisen K., Christ M. Rapid cardiovascular action of aldosterone in man. J. Clin. Endocrinol. Metab. 83:1998;3517-3522.
42. Romagni P., Rossi F., Guerrini L., Quirini C., Santiemma V. Aldosterone induces contraction of the resistance arteries in man. Atherosclerosis. 166:2003;345-349.
43. Wang W., McClain J.M., Zucker I.H. Aldosterone reduces baroreceptor discharge in the dog. Hypertension. 19:1992;270-277.
44. Zange J., Müller K., Gerzer R., Sippel K., Wehling M. Nongenomic effects of aldosterone on phosphocreatine levels in human calf muscle during recovery from exercise. J. Clin. Endocrinol. Metab. 81:1996;4296-4300.
45. Schmidt B.M., Georgens A.C., Martin N., Tillmann H.C., Feuring M., Christ M., Wehling M. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system. J. Clin. Endocrinol. Metab. 86:2001;761-767.